Skip to content
Open access

Lipid-based nanocarriers as versatile platforms for curcumin delivery in photodynamic therapy of skin cancer.

Ana Carolina Viana de Oliveira Lima Victória Meira Holanda Mateus Rebouças Mazza Geângela de Fátima Sousa Oliveira Márcia Carvalho de Abreu Fantini Cristiano Luis Pinto de Oliveira Eduardo Henrique Silva de Sousa T. Araújo J. Eloy R. Petrilli
Jul 2026 · International journal of pharmaceutics · Vol 702, pp. 127226 · 2 citations · 128 references
Medicine

TL;DR

The LNPs demonstrated skin penetration potential and enhanced phototoxic and cytotoxic effects on a non-melanoma skin carcinoma cell line compared to free curcumin, highlighting the potential of these nanosystems as drug delivery vehicles for the treatment of non-melanoma cancer.

Abstract

Non-melanoma skin cancer is one of the most frequent tumors, ranking as the fifth most common cancer. Photodynamic therapy is a noninvasive therapeutic option that involves the topical application of photosensitizers. In this context, curcumin, a polyphenolic compound extracted from Curcuma longa L., emerges as a safe alternative because of its potential phototoxic activity; however, it presents limitations such as poor skin penetration upon topical application and photodegradation. Among the promising strategies, the development of lipid nanoparticles, which are biocompatible and versatile systems, is noteworthy. In the present study, three curcumin lipid nanoparticles (LNPs) were developed and characterized, containing oleic acid, super refined castor oil, Phosal 50SA®, and Phosal 50PG® in PBS buffer, with 1.5% Poloxamer 407. The formation of these liquid crystalline phases was investigated. The LNPs exhibited mean particle sizes of 176 ± 6 nm(A1Cur), 169 ± 9 nm(C2Cur), 189 ± 19 nm(H3Cur), with corresponding PDIs of 0.133 ± 0.034; 0.226 ± 0.022 and 0.196 ± 0.009, and zeta potentials of -33 ± 1 mV; -26 ± 2 mV; -24 ± 2 mV for A1Cur, C2Cur and H3Cur, respectively. The encapsulation efficiency (EE%) was 89 ± 5% for A1Cur, 84 ± 6% for C2Cur, and 69 ± 6% for H3Cur, respectively. Small angle X-ray scattering (SAXS) revealed that only A1Cur exhibited a hexagonal liquid-crystalline phase morphology. In terms of in vitro skin penetration, A1Cur, C2Cur, and free curcumin exhibited transdermal effects, while H3Cur demonstrated greater topical potential. In ROS photogeneration assays, photoproduction was detected, particularly for LNP H3Cur. In vitro 24-hour cytotoxicity and phototoxicity against the A431 tumor cell line demonstrated that the cytotoxic and phototoxic effects were enhanced by the LNPs compared to free curcumin, especially for A1Cur. The liquid crystalline nanodispersions A1 and A1Cur were selected for incorporation into the dissolving microneedle systems, exhibiting good insertion capability and mechanical resistance to pressure. The LNPs demonstrated skin penetration potential and enhanced phototoxic and cytotoxic effects on a non-melanoma skin carcinoma cell line compared to free curcumin, highlighting the potential of these nanosystems as drug delivery vehicles for the treatment of non-melanoma cancer.

Read PDF

Similar papers

Open access Oct 2026

Curcumin-loaded lipid nanoparticles for photodynamic therapy in the topical treatment of melanoma.

Melanoma remains one of the deadliest skin cancers, and current therapies still struggle to combine efficacy with minimal invasiveness. Photodynamic therapy (PDT) is a promising alternative, yet its translation is hindered by poor photosensitizer (PS) solubility and difficulty achieving effective localized skin deliver...

Catarina Tavares, Zinaida Shakel, A. Granja et al. · 0 citations
Oct 2026

B-066 Development and Characterization of mPEG-Chitosan Nanoparticles for the Co-delivery of Curcumin and KRAS-targeting siRNA in Lung Cancer Models

Lung cancer represents one of the most lethal malignancies worldwide, exhibiting both high incidence and mortality rates. It remains the primary cause of cancer-related deaths among men and women. Several factors contribute to its lethality including late diagnosis and the limited effectiveness of current treatme...

Lujain Alkhalaileh, M. Bayachou · 0 citations
Review Sep 2026

Next-Generation Hybrid Nano-formulations for Polyphenolic Nutraceuticals in Cancer Therapy: An Overview.

A promising approach to cancer therapy is presented by integrating polyphenol-based nanoformulations into hybrid nanoformulations, addressing key limitations of conventional polyphenol delivery and thereby enhancing their anticancer potential through multiple molecular pathways.

Saloni Bhandari, Bhuvanesh Baniya, Supriya Singh et al. · 0 citations
Open access Sep 2026

Cobalt Ferrite Nanoparticles Conjugated with Methylene Blue: A Promising Approach for Photodynamic Therapy in Breast Cancer

Breast cancer, as the most frequently diagnosed malignancy, is the main cause of cancer mortality due to cancer all around the world among women. Therefore, developing effective breast cancer treatment approaches is crucial. Photodynamic therapy (PDT) is a novel and rapidly developing therapeutic approach that has been...

Hilal Çalık, B. Mısırlıoğlu, N. Kahya et al. · 0 citations
Open access Sep 2026

ZIF-8 Nanocarrier-Based Co-Delivery of Curcumin and 5-Fluorouracil for Synergistic Antitumor Activity in Hepatocellular Carcinoma

Background Hepatocellular carcinoma (HCC) is a highly prevalent malignancy worldwide, posing a severe threat to human health. Although conventional chemotherapy remains a primary treatment modality, its clinical efficacy is limited by poor targeting, drug resistance, and systemic toxicity. To address these challenges,...

Long Zhang, Wei-Jie Zhu, Lei He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.